BioMedInformatics | Free Full-Text | BDP1 Expression Correlates with Clinical Outcomes in Activated B-Cell Diffuse Large B-Cell Lymphoma | HTML
Expression of 5‐methylcytosine regulators is highly associated with the clinical phenotypes of prostate cancer and DNMTs expression predicts biochemical recurrence - Wang - - Cancer Medicine - Wiley Online Library
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches in: Endocrine-Related Cancer Volume 28 Issue 8 (2021)
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process | BMC Cancer | Full Text
Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response - eBioMedicine
![Prognostic values of the core components of the mammalian circadian clock in prostate cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/12539/1/fig-1-2x.jpg "Prognostic values of the core components of the mammalian circadian clock in prostate cancer [PeerJ]")
Prognostic values of the core components of the mammalian circadian clock in prostate cancer [PeerJ]
Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer - eBioMedicine
Identification of potential therapeutic targets in prostate cancer through a cross‐species approach | EMBO Molecular Medicine
Gene expression correlates of clinical prostate cancer behavior - ScienceDirect
Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy | Scientific Reports
miR‑769‑5p is associated with prostate cancer recurrence and modulates proliferation and apoptosis of cancer cells
Expression of CaT-like, a Novel Calcium-selective Channel, Correlates with the Malignancy of Prostate Cancer* - Journal of Biological Chemistry
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer | Oncogene
Genomic correlates of clinical outcome in advanced prostate cancer | PNAS
MELK expression correlates with tumor mitotic activity but is not required for cancer growth | eLife
BioMedInformatics | Free Full-Text | BDP1 Expression Correlates with Clinical Outcomes in Activated B-Cell Diffuse Large B-Cell Lymphoma | HTML
A novel gene expression test method of minimizing breast cancer risk in reduced cost and time by improving SVM-RFE gene selection method combined with LASSO
Gene expression arrays in cancer research: methods and applications - ppt download
Gene expression correlates of clinical prostate cancer behavior - ScienceDirect
Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer | Journal for ImmunoTherapy of Cancer
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression | Nature Communications
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome | PNAS
Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors | Journal of Nuclear Medicine
